[Surgical radiofrequency catheter ablation of accessory pathways in Ebstein's anomaly]

Leonardo Rivera Rodríguez1, Pedro Iturralde, Juan Calderń-Colmenero

  • 1Servicio de Cardiología Pediátrica y Electrofisiología, Instituto Nacional de Cardiología Ignacio Chávez, Tlalpan, México, DF. leonardoriv@hotmail.com

Insights

Surgical ablation therapy is a safe and effective treatment for patients with Ebstein anomaly and accessory pathways causing atrioventricular reentrant tachycardia. This study found a 100% success rate with no complications.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Congenital Heart Disease

Context:

  • Ebstein anomaly is a rare congenital heart condition.
  • Atrioventricular reentrant tachycardia (AVRT) is a common arrhythmia associated with Ebstein anomaly.
  • Accessory pathways are frequently identified in patients with Ebstein anomaly and AVRT.

Purpose:

  • To evaluate the safety and efficacy of surgical ablation for accessory pathways in patients with Ebstein anomaly and AVRT.

Summary:

  • Thirteen patients with Ebstein anomaly and AVRT underwent surgical radiofrequency catheter ablation or surgical section.
  • All accessory pathways were located in the tricuspid ring, predominantly on the right lateral free wall.
  • Surgical ablation achieved 100% success with no observed complications.

Impact:

  • Surgical ablation therapy is a safe and effective treatment option for accessory pathways in Ebstein anomaly patients.
  • This approach offers a high success rate and minimal risk, improving patient outcomes.